Clarius Group LLC purchased a brand new place in shares of GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report) within the third quarter, in keeping with its most up-to-date 13F submitting with the Securities and Change Fee (SEC). The agency purchased 2,448 shares of the corporate’s inventory, valued at roughly $229,000.
Different hedge funds have additionally not too long ago added to or diminished their stakes within the firm. Strategic Advisors LLC boosted its place in shares of GE HealthCare Applied sciences by 2.7% within the third quarter. Strategic Advisors LLC now owns 22,906 shares of the corporate’s inventory valued at $2,150,000 after buying an extra 599 shares through the interval. UMB Financial institution n.a. boosted its holdings in shares of GE HealthCare Applied sciences by 34.2% within the third quarter. UMB Financial institution n.a. now owns 2,058 shares of the corporate’s inventory value $193,000 after shopping for an extra 524 shares through the interval. Sanders Morris Harris LLC bought a brand new place in shares of GE HealthCare Applied sciences within the third quarter value roughly $233,000. BSN CAPITAL PARTNERS Ltd acquired a brand new stake in shares of GE HealthCare Applied sciences through the third quarter valued at roughly $4,646,000. Lastly, Patten Group Inc. lifted its place in shares of GE HealthCare Applied sciences by 41.3% within the third quarter. Patten Group Inc. now owns 7,521 shares of the corporate’s inventory valued at $706,000 after buying an extra 2,200 shares within the final quarter. Institutional traders and hedge funds personal 82.06% of the corporate’s inventory.
Insider Exercise
In associated information, CEO Thomas J. Westrick offered 2,750 shares of the corporate’s inventory in a transaction on Wednesday, August seventh. The shares had been offered at a median worth of $80.78, for a complete transaction of $222,145.00. Following the completion of the sale, the chief govt officer now immediately owns 17,509 shares of the corporate’s inventory, valued at roughly $1,414,377.02. This represents a 0.00 % lower of their place. The transaction was disclosed in a submitting with the Securities & Change Fee, which is accessible by means of this hyperlink. Insiders personal 0.27% of the corporate’s inventory.
Analysts Set New Value Targets
A number of analysts have issued experiences on the inventory. JPMorgan Chase & Co. started protection on shares of GE HealthCare Applied sciences in a analysis observe on Monday, September ninth. They set a “impartial” score and a $90.00 goal worth on the inventory. Evercore ISI upped their worth goal on GE HealthCare Applied sciences from $98.00 to $102.00 and gave the corporate an “outperform” score in a analysis report on Tuesday, October 1st. BTIG Analysis upgraded GE HealthCare Applied sciences from a “impartial” score to a “purchase” score and set a $100.00 worth goal for the corporate in a analysis report on Wednesday, September 18th. UBS Group downgraded GE HealthCare Applied sciences from a “impartial” score to a “promote” score and dropped their goal worth for the corporate from $84.00 to $74.00 in a report on Thursday, September twenty sixth. Lastly, Stifel Nicolaus raised their worth goal on shares of GE HealthCare Applied sciences from $100.00 to $102.00 and gave the inventory a “purchase” score in a report on Monday, September thirtieth. One equities analysis analyst has rated the inventory with a promote score, 5 have given a maintain score, seven have issued a purchase score and one has issued a robust purchase score to the corporate’s inventory. In line with MarketBeat.com, the inventory has a consensus score of “Reasonable Purchase” and a median worth goal of $94.23.
View Our Newest Evaluation on GE HealthCare Applied sciences
GE HealthCare Applied sciences Buying and selling Up 0.9 %
Shares of NASDAQ:GEHC opened at $91.03 on Friday. The corporate has a present ratio of 1.06, a fast ratio of 0.82 and a debt-to-equity ratio of 1.05. The inventory has a market capitalization of $41.55 billion, a PE ratio of 26.62, a P/E/G ratio of three.39 and a beta of 1.18. GE HealthCare Applied sciences Inc. has a 1 12 months low of $62.35 and a 1 12 months excessive of $94.55. The agency has a fifty day transferring common worth of $86.98 and a 200 day transferring common worth of $83.35.
GE HealthCare Applied sciences (NASDAQ:GEHC – Get Free Report) final launched its quarterly earnings outcomes on Wednesday, July thirty first. The corporate reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Applied sciences had a return on fairness of 25.26% and a internet margin of 8.10%. The corporate had income of $4.84 billion through the quarter, in comparison with the consensus estimate of $4.88 billion. Throughout the identical quarter within the prior 12 months, the corporate posted $0.92 EPS. The agency’s income was up .5% on a year-over-year foundation. Analysts anticipate that GE HealthCare Applied sciences Inc. will submit 4.26 EPS for the present fiscal 12 months.
GE HealthCare Applied sciences Publicizes Dividend
The enterprise additionally not too long ago declared a quarterly dividend, which shall be paid on Friday, November fifteenth. Shareholders of document on Friday, October 18th shall be issued a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.13%. GE HealthCare Applied sciences’s dividend payout ratio (DPR) is presently 3.51%.
GE HealthCare Applied sciences Profile
GE HealthCare Applied sciences Inc engages within the improvement, manufacture, and advertising and marketing of merchandise, companies, and complementary digital options used within the prognosis, therapy, and monitoring of sufferers in the US, Canada, and internationally. The corporate operates by means of 4 segments: Imaging, Ultrasound, Affected person Care Options, and Pharmaceutical Diagnostics.
Additional Studying
Need to see what different hedge funds are holding GEHC? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report).
Obtain Information & Rankings for GE HealthCare Applied sciences Day by day – Enter your e-mail tackle beneath to obtain a concise each day abstract of the newest information and analysts’ rankings for GE HealthCare Applied sciences and associated firms with MarketBeat.com’s FREE each day e-mail publication.
